vs

Side-by-side financial comparison of GLOBAL INDUSTRIAL Co (GIC) and Organogenesis Holdings Inc. (ORGO). Click either name above to swap in a different company.

GLOBAL INDUSTRIAL Co is the larger business by last-quarter revenue ($345.6M vs $37.2M, roughly 9.3× Organogenesis Holdings Inc.). On growth, GLOBAL INDUSTRIAL Co posted the faster year-over-year revenue change (14.3% vs -57.1%). Over the past eight quarters, GLOBAL INDUSTRIAL Co's revenue compounded faster (3.4% CAGR vs -46.5%).

Global Industrial Company is a Port Washington, New York–based company providing industrial and MRO products through a system of branded e-Commerce websites and relationship marketers in North America. The primary brand is Global Industrial.

Organogenesis Holdings Inc. is a leading regenerative medicine firm specializing in developing and manufacturing advanced therapeutic products for wound care, surgical repair, sports medicine, and dermatology. It serves healthcare providers and patients primarily in the U.S. and select international markets, offering clinically validated solutions for unmet medical needs.

GIC vs ORGO — Head-to-Head

Bigger by revenue
GIC
GIC
9.3× larger
GIC
$345.6M
$37.2M
ORGO
Growing faster (revenue YoY)
GIC
GIC
+71.4% gap
GIC
14.3%
-57.1%
ORGO
Faster 2-yr revenue CAGR
GIC
GIC
Annualised
GIC
3.4%
-46.5%
ORGO

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
GIC
GIC
ORGO
ORGO
Revenue
$345.6M
$37.2M
Net Profit
$14.6M
Gross Margin
34.5%
30.8%
Operating Margin
5.7%
-185.1%
Net Margin
4.2%
Revenue YoY
14.3%
-57.1%
Net Profit YoY
36.4%
EPS (diluted)
$0.37

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
GIC
GIC
ORGO
ORGO
Q1 26
$37.2M
Q4 25
$345.6M
$225.6M
Q3 25
$353.6M
$150.9M
Q2 25
$358.9M
$101.0M
Q1 25
$321.0M
$86.7M
Q4 24
$302.3M
$126.7M
Q3 24
$342.4M
$115.2M
Q2 24
$347.8M
$130.2M
Net Profit
GIC
GIC
ORGO
ORGO
Q1 26
Q4 25
$14.6M
$43.7M
Q3 25
$18.8M
$21.6M
Q2 25
$25.1M
$-9.4M
Q1 25
$13.6M
$-18.8M
Q4 24
$10.7M
$7.7M
Q3 24
$16.8M
$12.3M
Q2 24
$20.3M
$-17.0M
Gross Margin
GIC
GIC
ORGO
ORGO
Q1 26
30.8%
Q4 25
34.5%
Q3 25
35.6%
Q2 25
37.1%
Q1 25
34.9%
72.6%
Q4 24
33.8%
75.5%
Q3 24
34.0%
76.7%
Q2 24
35.2%
77.6%
Operating Margin
GIC
GIC
ORGO
ORGO
Q1 26
-185.1%
Q4 25
5.7%
28.1%
Q3 25
7.4%
13.7%
Q2 25
9.3%
-12.5%
Q1 25
5.7%
-30.9%
Q4 24
4.8%
8.1%
Q3 24
6.5%
5.4%
Q2 24
7.6%
-10.7%
Net Margin
GIC
GIC
ORGO
ORGO
Q1 26
Q4 25
4.2%
19.4%
Q3 25
5.3%
14.3%
Q2 25
7.0%
-9.3%
Q1 25
4.2%
-21.7%
Q4 24
3.5%
6.1%
Q3 24
4.9%
10.7%
Q2 24
5.8%
-13.1%
EPS (diluted)
GIC
GIC
ORGO
ORGO
Q1 26
Q4 25
$0.37
$0.31
Q3 25
$0.48
$0.11
Q2 25
$0.65
$-0.10
Q1 25
$0.35
$-0.17
Q4 24
$0.28
$0.05
Q3 24
$0.44
$0.09
Q2 24
$0.52
$-0.13

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
GIC
GIC
ORGO
ORGO
Cash + ST InvestmentsLiquidity on hand
$67.5M
$91.4M
Total DebtLower is stronger
Stockholders' EquityBook value
$313.2M
Total Assets
$580.8M
$520.0M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
GIC
GIC
ORGO
ORGO
Q1 26
$91.4M
Q4 25
$67.5M
$93.7M
Q3 25
$67.2M
$63.7M
Q2 25
$55.1M
$73.1M
Q1 25
$39.0M
$110.0M
Q4 24
$44.6M
$135.6M
Q3 24
$38.9M
$94.3M
Q2 24
$38.8M
$89.9M
Total Debt
GIC
GIC
ORGO
ORGO
Q1 26
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
$62.3M
Q2 24
$63.8M
Stockholders' Equity
GIC
GIC
ORGO
ORGO
Q1 26
Q4 25
$313.2M
$300.1M
Q3 25
$316.0M
$255.1M
Q2 25
$305.2M
$233.2M
Q1 25
$287.9M
$242.9M
Q4 24
$281.1M
$262.9M
Q3 24
$279.2M
$278.5M
Q2 24
$270.4M
$263.5M
Total Assets
GIC
GIC
ORGO
ORGO
Q1 26
$520.0M
Q4 25
$580.8M
$598.7M
Q3 25
$602.5M
$509.8M
Q2 25
$586.5M
$461.1M
Q1 25
$536.7M
$467.4M
Q4 24
$520.7M
$497.9M
Q3 24
$531.6M
$446.3M
Q2 24
$542.5M
$443.2M
Debt / Equity
GIC
GIC
ORGO
ORGO
Q1 26
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
0.22×
Q2 24
0.24×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
GIC
GIC
ORGO
ORGO
Operating Cash FlowLast quarter
$20.0M
Free Cash FlowOCF − Capex
$19.2M
FCF MarginFCF / Revenue
5.6%
Capex IntensityCapex / Revenue
0.2%
Cash ConversionOCF / Net Profit
1.37×
TTM Free Cash FlowTrailing 4 quarters
$74.7M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
GIC
GIC
ORGO
ORGO
Q1 26
Q4 25
$20.0M
$39.4M
Q3 25
$22.7M
$3.1M
Q2 25
$31.7M
$-32.9M
Q1 25
$3.4M
$-19.9M
Q4 24
$15.9M
$10.9M
Q3 24
$9.6M
$8.7M
Q2 24
$18.8M
$4.7M
Free Cash Flow
GIC
GIC
ORGO
ORGO
Q1 26
Q4 25
$19.2M
$34.8M
Q3 25
$22.0M
$844.0K
Q2 25
$30.3M
$-36.5M
Q1 25
$3.2M
$-23.6M
Q4 24
$15.2M
$7.6M
Q3 24
$8.7M
$6.1M
Q2 24
$17.9M
$2.9M
FCF Margin
GIC
GIC
ORGO
ORGO
Q1 26
Q4 25
5.6%
15.4%
Q3 25
6.2%
0.6%
Q2 25
8.4%
-36.1%
Q1 25
1.0%
-27.2%
Q4 24
5.0%
6.0%
Q3 24
2.5%
5.3%
Q2 24
5.1%
2.2%
Capex Intensity
GIC
GIC
ORGO
ORGO
Q1 26
Q4 25
0.2%
2.1%
Q3 25
0.2%
1.5%
Q2 25
0.4%
3.6%
Q1 25
0.1%
4.2%
Q4 24
0.2%
2.7%
Q3 24
0.3%
2.2%
Q2 24
0.3%
1.4%
Cash Conversion
GIC
GIC
ORGO
ORGO
Q1 26
Q4 25
1.37×
0.90×
Q3 25
1.21×
0.14×
Q2 25
1.26×
Q1 25
0.25×
Q4 24
1.49×
1.43×
Q3 24
0.57×
0.71×
Q2 24
0.93×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons